{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:28:34Z","timestamp":1789385314181,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T00:00:00Z","timestamp":1329696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T00:00:00Z","timestamp":1329696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>High mobility group box 1 protein (HMGB1) is a nuclear DNA binding protein acting as a pro-inflammatory mediator following extracellular release. HMGB1 has been increasingly recognized as a pathogenic mediator in several inflammatory diseases. Elevated serum levels of HMGB1 have been detected in autoimmune diseases including Systemic lupus erythematosus (SLE). However, the local expression of HMGB1 in active lupus nephritis (LN) is not known. Here we aimed to study both tissue expression and serum levels of HMGB1 in LN patients with active disease and after induction therapy.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Thirty-five patients with active LN were included. Renal biopsies were performed at baseline and after standard induction therapy; corticosteroids combined with immunosuppressive drugs. The biopsies were evaluated according to the World Health Organization (WHO) classification and renal disease activity was estimated using the British Isles lupus assessment group (BILAG) index. Serum levels of HMGB1 were analysed by western blot. HMGB1 expression in renal tissue was assessed by immunohistochemistry at baseline and follow-up biopsies in 25 patients.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Baseline biopsies showed WHO class III, IV or V and all patients had high renal disease activity (BILAG A\/B). Follow-up biopsies showed WHO I to II (<jats:italic>n<\/jats:italic> = 14), III (<jats:italic>n<\/jats:italic> = 6), IV (<jats:italic>n<\/jats:italic> = 3) or V (<jats:italic>n<\/jats:italic> = 12), and 15\/35 patients were regarded as renal responders (BILAG C\/D).<\/jats:p>\n                        <jats:p>At baseline HMGB1 was significantly elevated in serum compared to healthy controls (P &lt; 0.0001). In all patients, serum levels decreased only slightly; however, in patients with baseline WHO class IV a significant decrease was observed (P = 0.03). Immunostaining revealed a pronounced extranuclear HMGB1 expression predominantly outlining the glomerular endothelium and in the mesangium. There was no clear difference in HMGB1 expression comparing baseline and follow-up biopsies or any apparent association to histopathological classification or clinical outcome.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Renal tissue expression and serum levels of HMGB1 were increased in LN. The lack of decrease of HMGB1 in serum and tissue after immunosuppressive therapy in the current study may reflect persistent inflammatory activity. This study clearly indicates a role for HMGB1 in LN.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3747","type":"journal-article","created":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T15:14:59Z","timestamp":1329750899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis"],"prefix":"10.1186","volume":"14","author":[{"given":"Agneta","family":"Zickert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Palmblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Sundelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J","family":"Tracey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Bruchfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,20]]},"reference":[{"key":"3499_CR1","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"A Rahman","year":"2008","unstructured":"Rahman A, Isenberg DA: Systemic lupus erythematosus. N Engl J Med. 2008, 358: 929-939. 10.1056\/NEJMra071297.","journal-title":"N Engl J Med"},{"key":"3499_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","volume":"82","author":"R Cervera","year":"2003","unstructured":"Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC, Aydintug AO, Chwalinska-Sadowska H, de Ramon E, Fern\u00e1ndez-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR, European Working Party on Systemic Lupus Erythematosus: Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003, 82: 299-308. 10.1097\/01.md.0000091181.93122.55.","journal-title":"Medicine (Baltimore)"},{"key":"3499_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.2922595","volume":"243","author":"ME Bianchi","year":"1989","unstructured":"Bianchi ME, Beltrame M, Paonessa G: Specific recognition of cruciform DNA by nuclear protein HMG1. Science. 1989, 243: 1056-1059. 10.1126\/science.2922595.","journal-title":"Science"},{"key":"3499_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1365-2796.2003.01296.x","volume":"255","author":"S Muller","year":"2004","unstructured":"Muller S, Ronfani L, Bianchi ME: Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J Intern Med. 2004, 255: 332-343. 10.1111\/j.1365-2796.2003.01296.x.","journal-title":"J Intern Med"},{"key":"3499_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11926-008-0054-1","volume":"10","author":"RE Voll","year":"2008","unstructured":"Voll RE, Urbonaviciute V, Furnrohr B, Herrmann M, Kalden JR: The role of high-mobility group box 1 protein in the pathogenesis of autoimmune diseases. Curr Rheumatol Rep. 2008, 10: 341-342. 10.1007\/s11926-008-0054-1.","journal-title":"Curr Rheumatol Rep"},{"key":"3499_CR6","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1189\/jlb.72.6.1084","volume":"72","author":"U Andersson","year":"2002","unstructured":"Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ: HMGB1 as a DNA-binding cytokine. J Leukoc Biol. 2002, 72: 1084-1091.","journal-title":"J Leukoc Biol"},{"key":"3499_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/ar2440","volume":"10","author":"DS Pisetsky","year":"2008","unstructured":"Pisetsky DS, Erlandsson-Harris H, Andersson U: High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther. 2008, 10: 209-10.1186\/ar2440.","journal-title":"Arthritis Res Ther"},{"key":"3499_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbagrm.2009.11.003","volume":"1799","author":"U Andersson","year":"2010","unstructured":"Andersson U, Harris HE: The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim Biophys Acta. 2010, 1799: 141-148.","journal-title":"Biochim Biophys Acta"},{"key":"3499_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002, 418: 191-195. 10.1038\/nature00858.","journal-title":"Nature"},{"key":"3499_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2796.2003.01302.x","volume":"255","author":"H Wang","year":"2004","unstructured":"Wang H, Yang H, Tracey KJ: Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med. 2004, 255: 320-331. 10.1111\/j.1365-2796.2003.01302.x.","journal-title":"J Intern Med"},{"key":"3499_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1084\/jem.192.4.565","volume":"192","author":"U Andersson","year":"2000","unstructured":"Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000, 192: 565-570. 10.1084\/jem.192.4.565.","journal-title":"J Exp Med"},{"key":"3499_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2796.2003.01204.x","volume":"254","author":"CJ Treutiger","year":"2003","unstructured":"Treutiger CJ, Mullins GE, Johansson AS, Rouhiainen A, Rauvala HM, Erlandsson-Harris H, Andersson U, Yang H, Tracey KJ, Andersson J, Palmblad JE: High mobility group 1 B-box mediates activation of human endothelium. J Intern Med. 2003, 254: 375-385. 10.1046\/j.1365-2796.2003.01204.x.","journal-title":"J Intern Med"},{"key":"3499_CR13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/01.CCM.0000155991.88802.4D","volume":"33","author":"J Sunden-Cullberg","year":"2005","unstructured":"Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ, Lee ML, Andersson J, Tokics L, Treutiger CJ: Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med. 2005, 33: 564-573. 10.1097\/01.CCM.0000155991.88802.4D.","journal-title":"Crit Care Med"},{"key":"3499_CR14","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1002\/art.10540","volume":"46","author":"R Kokkola","year":"2002","unstructured":"Kokkola R, Sundberg E, Ulfgren AK, Palmblad K, Li J, Wang H, Ulloa L, Yang H, Yan XJ, Furie R, Chiorazzi N, Tracey KJ, Andersson U, Harris HE: High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum. 2002, 46: 2598-2603. 10.1002\/art.10540.","journal-title":"Arthritis Rheum"},{"key":"3499_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2119\/2006-00108.Goldstein","volume":"13","author":"RS Goldstein","year":"2007","unstructured":"Goldstein RS, Bruchfeld A, Yang L, Qureshi AR, Gallowitsch-Puerta M, Patel NB, Huston BJ, Chavan S, Rosas-Ballina M, Gregersen PK, Czura CJ, Sloan RP, Sama AE, Tracey KJ: Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med. 2007, 13: 210-215.","journal-title":"Mol Med"},{"key":"3499_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2119\/molmed.2010.00132","volume":"17","author":"A Bruchfeld","year":"2011","unstructured":"Bruchfeld A, Wendt M, Bratt J, Qureshi AR, Chavan S, Tracey KJ, Palmblad K, Gunnarsson I: High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations. Mol Med. 2011, 17: 29-35.","journal-title":"Mol Med"},{"key":"3499_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2119\/2007-00107.Bruchfeld","volume":"14","author":"A Bruchfeld","year":"2008","unstructured":"Bruchfeld A, Qureshi AR, Lindholm B, Barany P, Yang L, Stenvinkel P, Tracey KJ: High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD). Mol Med. 2008, 14: 109-115. 10.1007\/s00894-007-0256-x.","journal-title":"Mol Med"},{"key":"3499_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1189\/jlb.0306196","volume":"81","author":"V Urbonaviciute","year":"2007","unstructured":"Urbonaviciute V, Furnrohr BG, Weber C, Haslbeck M, Wilhelm S, Herrmann M, Voll RE: Factors masking HMGB1 in human serum and plasma. J Leukoc Biol. 2007, 81: 67-74.","journal-title":"J Leukoc Biol"},{"key":"3499_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/ard.2007.074484","volume":"67","author":"W Jiang","year":"2008","unstructured":"Jiang W, Pisetsky DS: Expression of high mobility group protein 1 in the sera of patients and mice with systemic lupus erythematosus. Ann Rheum Dis. 2008, 67: 727-728.","journal-title":"Ann Rheum Dis"},{"key":"3499_CR20","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3899\/jrheum.090663","volume":"37","author":"J Li","year":"2010","unstructured":"Li J, Xie H, Wen T, Liu H, Zhu W, Chen X: Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. J Rheumatol. 2010, 37: 766-775. 10.3899\/jrheum.090663.","journal-title":"J Rheumatol"},{"key":"3499_CR21","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1177\/0961203307081895","volume":"16","author":"V Barkauskaite","year":"2007","unstructured":"Barkauskaite V, Ek M, Popovic K, Harris HE, Wahren-Herlenius M, Nyberg F: Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus. 2007, 16: 794-802. 10.1177\/0961203307081895.","journal-title":"Lupus"},{"key":"3499_CR22","doi-asserted-by":"publisher","first-page":"R71","DOI":"10.1186\/ar3332","volume":"13","author":"DA Abdulahad","year":"2011","unstructured":"Abdulahad DA, Westra J, Bijzet J, Limburg PC, Kallenberg CG, Bijl M: High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Arthritis Res Ther. 2011, 13: R71-10.1186\/ar3332.","journal-title":"Arthritis Res Ther"},{"key":"3499_CR23","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 1271-1277. 10.1002\/art.1780251101.","journal-title":"Arthritis Rheum"},{"key":"3499_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470.","journal-title":"Ann Intern Med"},{"key":"3499_CR25","volume-title":"Renal Disease: Classification and Atlas of Glomerular Diseases","author":"J Churg","year":"1995","unstructured":"Churg J, Bernstein J, Glassock RJ: Renal Disease: Classification and Atlas of Glomerular Diseases. 1995, New York, Tokyo: Igakuso Shoin, 2","edition":"2"},{"key":"3499_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","volume":"75","author":"HA Austin","year":"1983","unstructured":"Austin HA, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE: Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med. 1983, 75: 382-391. 10.1016\/0002-9343(83)90338-8.","journal-title":"Am J Med"},{"key":"3499_CR27","first-page":"447","volume":"86","author":"EM Hay","year":"1993","unstructured":"Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, Symmons DP, Viner N, Zoma A: The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med. 1993, 86: 447-458.","journal-title":"Q J Med"},{"key":"3499_CR28","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","volume":"44","author":"DA Isenberg","year":"2005","unstructured":"Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, D'Cruz D, Griffiths B, Khamashta M, Maddison P McHugh N, Snaith M, The LS, Yee CS, Zoma A, Gordon C: BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford). 2005, 44: 902-906. 10.1093\/rheumatology\/keh624.","journal-title":"Rheumatology (Oxford)"},{"key":"3499_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/rheumatology\/kep064","volume":"48","author":"CS Yee","year":"2009","unstructured":"Yee CS, Farewell V, Isenberg DA, Griffiths B, Teh LS, Bruce IN, Ahmad Y, Rahman A, Prabu A, Akil M, McHugh N, Edwards C, D'Cruz D, Khamashta MA, Maddison P, Gordon C: The BILAG-2004 index is sensitive to change for assessment of SLE disease activity. Rheumatology (Oxford). 2009, 48: 691-695. 10.1093\/rheumatology\/kep064.","journal-title":"Rheumatology (Oxford)"},{"key":"3499_CR30","first-page":"693","volume":"29","author":"I Gunnarsson","year":"2002","unstructured":"Gunnarsson I, Sundelin B, Heimburger M, Forslid J, van Vollenhoven R, Lundberg I, Jacobson SH: Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria. J Rheumatol. 2002, 29: 693-699.","journal-title":"J Rheumatol"},{"key":"3499_CR31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1523-1755.2001.00492.x","volume":"59","author":"GS Hill","year":"2001","unstructured":"Hill GS, Delahousse M, Nochy D, Remy P, Mignon F, Mery JP, Bariety J: Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int. 2001, 59: 304-316.","journal-title":"Kidney Int"},{"key":"3499_CR32","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1046\/j.1523-1755.2001.00730.x","volume":"59","author":"CC Najafi","year":"2001","unstructured":"Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J: Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int. 2001, 59: 2156-2163.","journal-title":"Kidney Int"},{"key":"3499_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.autrev.2008.07.015","volume":"8","author":"C Janko","year":"2008","unstructured":"Janko C, Schorn C, Grossmayer GE, Frey B, Herrmann M, Gaipl US, Munoz LE: Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE). Autoimmun Rev. 2008, 8: 9-12. 10.1016\/j.autrev.2008.07.015.","journal-title":"Autoimmun Rev"},{"key":"3499_CR34","doi-asserted-by":"publisher","first-page":"C1318","DOI":"10.1152\/ajpcell.00616.2005","volume":"291","author":"CW Bell","year":"2006","unstructured":"Bell CW, Jiang W, Reich CF, Pisetsky DS: The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol. 2006, 291: C1318-1325. 10.1152\/ajpcell.00616.2005.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3499_CR35","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s10495-010-0478-8","volume":"15","author":"K Kruse","year":"2010","unstructured":"Kruse K, Janko C, Urbonaviciute V, Mierke CT, Winkler TH, Voll RE, Schett G, Munoz LE, Herrmann M: Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players. Apoptosis. 2010, 15: 1098-1113. 10.1007\/s10495-010-0478-8.","journal-title":"Apoptosis"},{"key":"3499_CR36","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1084\/jem.20081165","volume":"205","author":"V Urbonaviciute","year":"2008","unstructured":"Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, Bianchi ME, Kirschning C, Wagner H, Manfredi AA, Kalden JR, Schett G, Rovere-Querini P, Herrmann M, Voll RE: Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med. 2008, 205: 3007-3018. 10.1084\/jem.20081165.","journal-title":"J Exp Med"},{"key":"3499_CR37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/s10165-009-0151-7","volume":"19","author":"A Hayashi","year":"2009","unstructured":"Hayashi A, Nagafuchi H, Ito I, Hirota K, Yoshida M, Ozaki S: Lupus antibodies to the HMGB1 chromosomal protein: epitope mapping and association with disease activity. Mod Rheumatol. 2009, 19: 283-292. 10.1007\/s10165-009-0151-7.","journal-title":"Mod Rheumatol"},{"key":"3499_CR38","first-page":"332","volume":"34","author":"L Christopher-Stine","year":"2007","unstructured":"Christopher-Stine L, Siedner M, Lin J, Haas M, Parekh H, Petri M, Fine DM: Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol. 2007, 34: 332-335.","journal-title":"J Rheumatol"},{"key":"3499_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/0961203308100481","volume":"18","author":"C Gordon","year":"2009","unstructured":"Gordon C, Jayne D, Pusey C, Adu D, Amoura Z, Aringer M, Ballerin J, Cervera R, Calvo-Al\u00e9n J, Chizzolini C, Dayer J, Doria A, Ferrario F, Floege J, Guillevin L, Haubitz M, Hiepe F, Houssiau F, Lesavre P, Lightstone L, Meroni P, Meyer O, Moulin B, O'Reilly K, Praga M, Schulze-Koops H, Sinico R, Smith K, Tincani A, Vasconcelos C, et al: European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus. 2009, 18: 257-263. 10.1177\/0961203308100481.","journal-title":"Lupus"},{"key":"3499_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbagrm.2009.11.019","volume":"1799","author":"H Yang","year":"2010","unstructured":"Yang H, Tracey KJ: Targeting HMGB1 in inflammation. Biochim Biophys Acta. 2010, 1799: 149-156.","journal-title":"Biochim Biophys Acta"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3747.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3747\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3747.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:27:59Z","timestamp":1728383279000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,20]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,2]]}},"alternative-id":["3499"],"URL":"https:\/\/doi.org\/10.1186\/ar3747","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,20]]},"assertion":[{"value":"17 May 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R36"}}